Literature DB >> 17925424

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.

Dominick E Shaw1, Michael A Berry, Bev Hargadon, Susan McKenna, Maria J Shelley, Ruth H Green, Christopher E Brightling, Andrew J Wardlaw, Ian D Pavord.   

Abstract

BACKGROUND: There is debate about the mechanisms of persistent airflow limitation in patients with asthma. Chronic inflammation is assumed to be important, although there is limited and contradictory information about the relationship between airway inflammation and postbronchodilator FEV1.
METHODS: We have assessed the cross-sectional relationship between prebronchodilator and postbronchodilator FEV1 and measures of airway inflammation after allowing for the effects of potential confounding factors. Multivariate analysis was performed on data collected from 1,197 consecutive patients with asthma seen at the respiratory outpatient clinic at Glenfield Hospital between 1997 and 2004. Relationships between induced sputum total neutrophil and differential eosinophil cell counts, and prebronchodilator and postbronchodilator lung function were examined.
RESULTS: Sputum total neutrophil but not differential eosinophil count was associated with lower postbronchodilator FEV1. Both differential eosinophil and total neutrophil count were associated with lower prebronchodilator FEV1. These effects were independent after adjustment for age, smoking, ethnicity, asthma duration, and inhaled corticosteroid use. A 10-fold increase in neutrophil count was associated with a 92 mL reduction (95% confidence interval, 29 to 158; p = 0.007) in postbronchodilator FEV1.
CONCLUSIONS: In this large heterogeneous population of adults with asthma, we have shown that prebronchodilator FEV1 is associated with neutrophilic and eosinophilic airway inflammation, whereas sputum total neutrophil counts alone are associated with postbronchodilator FEV1. This supports the hypothesis that neutrophilic airway inflammation has a role in the progression of persistent airflow limitation in asthma and raises the possibility that this progression and the development of COPD share a common mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925424     DOI: 10.1378/chest.07-1047

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  73 in total

1.  A comparison of the clinical and induced sputum characteristics of early- and late-onset asthma.

Authors:  Matthew Rossall; Paul Cadden; Umme Kolsum; Dave Singh
Journal:  Lung       Date:  2012-04-08       Impact factor: 2.584

2.  Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression.

Authors:  Regina R Pillai; Rohit Divekar; Allan Brasier; Suresh Bhavnani; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 3.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

Review 4.  Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling.

Authors:  Albert van der Vliet; Yvonne M W Janssen-Heininger; Vikas Anathy
Journal:  Mol Aspects Med       Date:  2018-08-22

5.  Apolipoprotein A-I attenuates ovalbumin-induced neutrophilic airway inflammation via a granulocyte colony-stimulating factor-dependent mechanism.

Authors:  Cuilian Dai; Xianglan Yao; Karen J Keeran; Gayle J Zywicke; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

6.  Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma.

Authors:  Mang Yu; Michael R Eckart; Alexander A Morgan; Kaori Mukai; Atul J Butte; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

7.  ATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.

Authors:  Cuilian Dai; Xianglan Yao; Boris Vaisman; Todd Brenner; Katharine S Meyer; Meixia Gao; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 8.  Epidemiology of the origins of airflow limitation in asthma.

Authors:  Stefano Guerra; Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-12

9.  Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice.

Authors:  Efrossini Dima; Nikoletta Rovina; Christina Gerassimou; Charis Roussos; Christina Gratziou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

10.  Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.

Authors:  Sumit Gupta; Salman Siddiqui; Pranab Haldar; James J Entwisle; Dean Mawby; Andrew J Wardlaw; Peter Bradding; Ian D Pavord; Ruth H Green; Christopher E Brightling
Journal:  Thorax       Date:  2010-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.